Abiopharma

🔍 ANDERSON RICHARD H (Director)

Company: NORFOLK SOUTHERN CORP (NSC)

Report Date: 2026-08-20

Detailed Transactions and Holdings:

• Acquired 7 shares of Deferred Stock Units - Dir. Def. Fee Plan (Derivative)
  Date: 2026-08-20 | Code: A | equity_swap_involved: 0 | shares_owned_after: 1,771.04 | transaction_form_type: 4 | Footnotes: F1, F1, F1, F1, F1, F1
• Acquired 9 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-20 | Code: A | equity_swap_involved: 0 | shares_owned_after: 2,388.41 | transaction_form_type: 4 | Footnotes: F2, F2, F2, F2, F2, F2

Footnotes:

• F1: Reports the number of deferred stock units credited to the reporting person's account in the Norfolk Southern Corporation Directors' Deferred Fee Plan in the form of a deemed reinvestment of dividends on deferred stock units held under the plan, calculated on the basis of the closing market value of the company's common stock on the dividend payment date. These units ultimately will be satisfied in cash, not in shares of common stock, upon the reporting person's retirement or at such other time as may be elected under the terms of the plan.
• F2: Reports the number of restricted stock units credited to the reporting person's account in the Norfolk Southern Corporation Long-Term Incentive Plan in the form of dividend equivalent payments on restricted stock units held under the plan, calculated on the basis of the market value of the corporation's common stock on the dividend payment date. These units ultimately will be satisfied in common stock.